Cannabis More Effective in Treating Musculoskeletal Pain ThanTraditional Medications, Patients Say in New Study

nacbcomdev on July 29, 2024

LOS ANGELES, CA — A new study conducted by researchers at the University of California has found that patients with musculoskeletal pain report cannabis to be more effective than traditional medications in managing their symptoms. The study surveyed over 1,500 patients who utilize cannabis as a treatment option, highlighting its efficacy compared to conventional pain relief methods.

Study Insights

The findings revealed that:

  • 80% of participants indicated significant pain relief from cannabis, particularly products high in THC and CBD.
  • Many respondents noted a reduction in their reliance on opioid medications, with cannabis serving as a safer alternative for pain management.
  • The most commonly used forms of cannabis included oils, edibles, and vaporized products, which patients reported as effective methods for alleviating pain without the adverse side effects associated with traditional medications.

Patient Experiences

Participants shared their personal experiences with cannabis for pain relief. One patient remarked, “Switching to cannabis has transformed my life. I can manage my pain effectively without the foggy feeling that comes with opioids.” Another participant added, “Cannabis has allowed me to engage in activities I enjoy without being hindered by pain.”

Implications for Pain Management

The study’s results underscore the potential of cannabis as a viable option for treating chronic pain, especially as the medical community seeks alternatives to opioids amid the ongoing crisis. Dr. Emily Thompson, a lead researcher, stated, “Our findings highlight the importance of considering cannabis in pain management strategies. As more states legalize medical cannabis, healthcare providers should evaluate its role in treatment plans.”

Future Directions

As the dialogue surrounding cannabis and its medicinal properties continues to evolve, this study contributes to the growing body of evidence supporting its use for pain management. With increasing patient testimonials and clinical research backing its effectiveness, cannabis is set to play a significant role in the future of pain treatment.

Healthcare professionals and policymakers are encouraged to consider these findings as they navigate the complexities of cannabis legalization and its integration into standard medical practices. The study serves as a call for further research into cannabis as a legitimate treatment option, potentially reshaping pain management approaches in the coming years.

Public Comment Period for Marijuana Rescheduling Ends, Next Steps Await

nacbcomdev on July 28, 2024

WASHINGTON, D.C. — The Biden Administration’s proposal to reschedule marijuana under the Controlled Substances Act (CSA) has officially concluded its public comment period. The Department of Justice (DOJ) and Drug Enforcement Administration (DEA) received an unprecedented 42,925 comments from the public, underscoring the significant interest and stakes involved in this issue.

Overwhelming Support for Broader Reform

Analysis of the public comments reveals a strong push for more comprehensive reforms. According to the Drug Policy Alliance (DPA), 69.3% of comments advocate for the rescheduling, decriminalization, or outright legalization of marijuana at the federal level. This widespread sentiment highlights the perceived shortcomings of merely rescheduling marijuana to Schedule III, which would still uphold federal criminalization and its associated penalties.

Next Steps in the Rulemaking Process

With the public comment period now closed, the DOJ and DEA will begin reviewing the submissions, considering the feedback as they work towards finalizing the rescheduling rule. If an administrative hearing is deemed necessary to gather additional input, further notice will be published in the Federal Register.

The timeline for completing the review and finalizing the rule remains uncertain, as the DEA has not specified the duration of this process. However, stakeholders are urging the agencies to expedite this critical reform.

Potential Implications for the Cannabis Industry

Rescheduling marijuana to Schedule III could ease some restrictions on cannabis-related research and modify the legal framework for manufacturers and distributors. Notably, it would eliminate the prohibition on claiming federal tax deductions for marijuana business expenses under Section 280E of the Internal Revenue Code.

Nevertheless, several key questions remain unresolved, such as whether marijuana will require a prescription and specific registration for manufacturers and distributors, and how rescheduling might impact existing state medical marijuana laws.

A Call for Further Action

Despite the closure of the public comment period, the call for comprehensive cannabis reform continues. The overwhelming support for rescheduling or decriminalization signals a need for the Biden Administration to exceed the modest rescheduling proposal and address the enduring harms of marijuana criminalization.

As the rulemaking process advances, stakeholders will vigilantly monitor the actions of the DOJ and DEA, continuing to advocate for a more equitable and just federal cannabis policy.

Ohio DDC Issues First Adult-Use Marijuana Licenses Following Issue 2Approval

nacbcomdev on July 28, 2024

COLUMBUS, OH — The Ohio Department of Commerce has officially issued the state’s first adult-use marijuana licenses, marking a significant milestone in the implementation of Issue 2, which legalized recreational cannabis in Ohio. This historic move follows months of regulatory preparation and is set to transform the state’s cannabis landscape.

The initial licenses are being granted primarily to existing medical marijuana operators, who have been given priority in the application process. This strategic decision aims to streamline the transition into the adult-use market while ensuring that established operators can quickly adapt to the new regulations. According to the Ohio Division of Cannabis Control (DCC), adult-use stores could begin operating as soon as this summer.

Key Details of the Licensing Process

The DCC has outlined a comprehensive framework for the licensing process, which includes:

  • Dual-Use Licenses: Current medical marijuana facilities can apply for dual-use licenses, allowing them to operate in both the medical and adult-use markets. This approach facilitates a smoother transition for operators already familiar with the state’s regulatory environment.
  • Provisional Licenses: The DCC plans to issue provisional licenses by September 7, 2024, enabling operators to commence adult-use sales while finalizing compliance with state regulations.
  • Social Equity Considerations: As part of the implementation of Issue 2, the DCC is also focused on incorporating social equity provisions. These measures aim to ensure that communities disproportionately impacted by past cannabis prohibition have opportunities to participate in the new market.

Industry Implications

The introduction of adult-use marijuana licenses is expected to have a profound impact on Ohio’s cannabis industry. With the potential for adult-use stores to open soon, the DCC anticipates significant market expansion, providing consumers with greater access to cannabis products.

However, questions remain regarding the long-term effects on the existing medical marijuana program and how the new adult-use market will coexist with it. Stakeholders are eager to understand the implications of these changes, particularly concerning pricing, product availability, and regulatory compliance.

Looking Ahead

As Ohio moves forward with its adult-use cannabis program, the DCC is committed to transparency and stakeholder engagement. A panel discussion hosted by the Drug Enforcement and Policy Center is scheduled for July 16, where experts will address key topics related to the implementation of Issue 2, including regulatory challenges and social equity initiatives.

The issuance of the first adult-use marijuana licenses marks a pivotal moment for Ohio, reflecting the state’s commitment to embracing cannabis reform and creating a regulated market that benefits all stakeholders involved. As the landscape evolves, the DCC will continue to monitor developments and adjust regulations to ensure a successful rollout of adult-use cannabis in Ohio.

Potential Biden Successors Show Support for Cannabis Reform

nacbcomdev on July 27, 2024

WASHINGTON, D.C. — As speculation swirls around President Joe Biden’s potential successors, a common thread emerges: support for cannabis reform. Several high-profile Democrats, including Vice President Kamala Harris and Governors Gavin Newsom and Gretchen Whitmer, have expressed varying degrees of openness to advancing marijuana legislation.

Vice President Kamala Harris, a leading contender, has been vocal about her views on cannabis. During her presidential campaign, Harris pledged to decriminalize marijuana at the federal level and expunge prior convictions. As a senator, she co-sponsored the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which aimed to deschedule cannabis from the Controlled Substances Act.

California Governor Gavin Newsom has been a longtime advocate for cannabis reform. In 2016, he supported the Adult Use of Marijuana Act, which legalized recreational marijuana in the state. Despite challenges such as excessive taxes and regulations that have hindered the growth of California’s regulated cannabis market, Newsom’s commitment to the industry has remained steadfast.

Michigan Governor Gretchen Whitmer has also demonstrated support for cannabis. Under her leadership, Michigan’s regulated marijuana industry has flourished, recently surpassing California’s in size. This growth highlights the strength of the legal market in the Great Lakes State.

While these potential successors have shown varying levels of support for cannabis reform, their openness to the issue contrasts with the stance of some Republicans. Former Attorney General Bill Barr, perceived as a Trump Administration surrogate, has spoken out against rescheduling marijuana, raising concerns about the potential rollback of Biden-era reforms.

The cannabis industry and advocates eagerly await further clarity on how these potential successors would approach marijuana policy if elected. As the Democratic Party navigates the path forward, the support for cannabis reform among the potential candidates could shape the future of federal cannabis legislation.

Cannabis Operators Turn to Ganjier Program to Educate Employees

nacbcomdev on July 26, 2024

SACRAMENTO, CA — As the cannabis industry continues to evolve, operators are increasingly turning to the Ganjier program to enhance employee education and expertise. The Ganjier Product Specialist program offers comprehensive training through online courses, live training sessions, and in-person examinations, equipping employees with the knowledge needed to elevate customer experiences in dispensaries.

Modeled after sommelier training in the wine industry, the Ganjier program aims to create a new class of cannabis professionals capable of assessing quality and guiding consumers in their product choices. “Every other epicurean field has long had trained professionals that assess quality and guide consumers. That simply didn’t exist in cannabis before Ganjier,” stated Derek Gilman, Managing Director of Ganjier.

Comprehensive Training Approach

The Ganjier program encompasses a variety of educational formats, including:

  • Online Courses: Participants can access modules covering cannabis quality assessment, customer interaction protocols, and the sensory evaluation of cannabis products.
  • Live Training: Conducted at the Ganjier campus in Humboldt County, California, these sessions provide hands-on experience with industry experts known as the Ganjier Council. Students engage in practical assessments of cannabis quality, learning to evaluate products based on aroma, appearance, flavor, and effect.
  • In-Person Exams: Graduates must demonstrate proficiency through rigorous examinations, including a written test, service exam, and assessment exam, ensuring they are well-prepared to serve consumers effectively.

Industry Impact

With nearly 300 certified Ganjiers worldwide, the program is rapidly gaining recognition as a vital resource for cannabis operators. The diverse student body includes multigenerational craft cultivators, budtenders, retail managers, and even former athletes like Ricky Williams, who praised the program for enhancing his understanding of cannabis quality.

“Ganjier has provided me with the necessary tools to bring these principles to life in my teaching and experiences,” said Dharshini Casinathen, a Certified Ganjier and owner of Joy Leaf NJ.

Elevating Standards

The Ganjier program not only empowers employees but also aims to elevate industry standards across the board. By training a new generation of cannabis professionals, the program addresses the growing demand for knowledgeable staff in dispensaries, ensuring consumers receive informed guidance when selecting products.

As the cannabis landscape continues to expand, the Ganjier program stands out as a pioneering initiative shaping the future of cannabis education and consumer experience. With plans for future classes and advanced training opportunities, Ganjier is poised to play a crucial role in the ongoing development of the cannabis industry.

Majority of New York Medical Marijuana Patients Report Reduced Opioid Use

nacbcomdev on July 26, 2024

NEW YORK, NY — A recent survey by the New York State Department of Health reveals that a significant portion of medical marijuana patients in the state have reduced their use of prescription opioids and other medications since initiating cannabis treatment. This finding underscores the potential of medical marijuana as an alternative to opioids for pain management.

The survey, which encompassed responses from over 10,000 participants in the New
York Medical Marijuana Program, highlights that:

  • 66% of patients reported a specific reduction in their reliance on prescription opioids for pain relief.
  • Two-thirds of patients overall indicated that cannabis has led to a decrease in their use of prescription opioids and other drugs.

These results corroborate previous studies suggesting that access to medical marijuana may contribute to reduced opioid prescribing and lower overdose rates. In 2018, the New York State Department of Health added opioid use disorder as a qualifying condition for medical marijuana, citing research that demonstrated cannabis’s potential to mitigate opioid use.

“Research indicates that marijuana can reduce opioid consumption. By including opioid use as a qualifying condition for medical marijuana, we aim to save countless lives across New York State,” stated Dr. Howard Zucker, New York State Health Commissioner, in the 2018 announcement.

With over 124,000 patients certified and more than 3,500 clinicians registered as medical cannabis providers as of February 2022, the New York Medical Marijuana Program is expanding steadily. The survey’s findings emphasize the importance of broadening access to medical cannabis as part of a harm reduction strategy in the ongoing opioid crisis.

“It is crucial that both practitioners and patients have access to diverse alternatives to opioids,” remarked Assembly Health Committee Chair Richard N. Gottfried. “Evidence from across the nation indicates that medical marijuana for pain management significantly reduces the use of more dangerous opioids.”

As New York’s medical marijuana program continues to evolve, further research is
essential to fully understand the dynamics between cannabis use and opioid dependency.
However, the patient-reported data from this survey offers promising real-world evidence
of marijuana’s potential to alleviate opioid dependence and reduce overdose risks.

California Cannabis Operators Pivot to Comply with New Vape Law

nacbcomdev on July 26, 2024

SACRAMENTO, CA — California’s cannabis industry is undergoing significant changes as operators adapt to a new vape law that took effect on July 1, 2024. Aimed at enhancing environmental sustainability and consumer safety, the legislation prohibits the use of the term “disposable” in advertising and labeling for vape products, prompting brands and retailers to rethink their packaging and disposal practices.

Industry Response and Compliance Initiatives

In response to the new regulations, cannabis companies across the state are implementing various strategies to ensure compliance. Perfect Union, a Sacramento-based retailer with nine locations, is proactively educating customers about the proper disposal of vape products, emphasizing the need to treat them as hazardous waste rather than regular trash. Angelica Sanchez, the senior director of government affairs and compliance at Perfect Union, stated, “This initiative is crucial for promoting environmentally responsible practices among our customers.”

Industry Response and Compliance Initiatives

To facilitate proper disposal, Perfect Union is installing vape disposal boxes at all its stores, providing a convenient solution for customers looking to dispose of their used products safely.

Packaging Overhaul

Brands are also making significant adjustments to their packaging. Final Bell Holdings, a Los Angeles-based supply chain service provider, is assisting its clients in updating existing labels and creating new packaging that complies with the new law. CEO Jeremy Green highlighted the absence of dedicated recycling solutions for cannabis vaporization products, indicating a pressing need for industry-wide innovation.

Mammoth Distribution, which distributes the popular Heavy Hitters brand, aligned its product packaging months in advance to meet the new compliance standards. Wesley Hein, head of global brand expansion at Mammoth, noted that the company has been integrating the bill’s language into its marketing and educational materials to ensure clarity for consumers.

Sustainable Practices

In addition to compliance, many brands are focusing on sustainability. Pax Labs, a leading manufacturer of cannabis vaping devices, recently launched a vape device made from reclaimed and recycled ocean-bound plastic. Scott Collins, the senior director of hardware product and design at Pax Labs, emphasized the importance of responsible consumption and disposal, stating, “We are keen to see not just responsible consumption but responsible disposal as well.”

Challenges Ahead

While the new vape law represents a step toward improved sustainability in the cannabis industry, challenges remain regarding enforcement and consumer education. Experts, including cannabis attorney Paula Savchenko, have raised concerns about the Department of Cannabis Control’s ability to effectively enforce the new regulations amid ongoing issues in the marketplace.

As California continues to set the standard for environmental policy and sustainability initiatives, the cannabis industry’s response to this new vape law will likely serve as a model for other states considering similar legislation. The ongoing adaptation of operators highlights the commitment to creating a safer and more sustainable cannabis environment for all stakeholders involved.

California State Fair Makes History with On-Site Cannabis Sales and Consumption

nacbcomdev on July 26, 2024

SACRAMENTO, Calif. — The 2024 California State Fair has made history by becoming the first state sanctioned fair to permit on-site cannabis sales and consumption. This groundbreaking initiative, introduced at Cal Expo, integrates the burgeoning cannabis industry into one of California’s most cherished events.

A New Experience

Running until July 30, the fair features a dedicated cannabis consumption lounge, offering a novel experience for attendees aged 21 and older. Lauren Carpenter, founder and CEO of Embarc, a leading cannabis retailer involved in the initiative, remarked, “We’re literally making history at the California State Fair. This is the first time this has happened at any state fair in the world.”

This year marks the third consecutive appearance of a cannabis exhibit at the California State Fair, but it is the first to allow consumption. Visitors can access the cannabis consumption lounge through the “CA Cannabis Exhibit” in Building Six of the fair’s Exhibit Hall. Attendees must scan their IDs and navigate through an educational exhibit on the history of cannabis in California before entering the lounge.

Unique Offerings and Experience

Inside the lounge, guests can purchase cannabis-infused products such as CBD slushies and partake in interactive activities. The consumption area is designed to be distinct and separate from the main fairgrounds, ensuring that the event remains family-friendly.

Safety and Regulations

To ensure safety and regulatory compliance, all cannabis products consumed on-site must be purchased at the fair; outside cannabis is prohibited. Items must remain sealed when transported outside the designated consumption areas. Comprehensive security measures are in place to facilitate a smooth experience for all attendees.

“The consumption area is located well away from the main fair activities,” Carpenter explained. “We’ve collaborated for about a year with regulatory agencies and community stakeholders to design this space with the utmost sensitivity and appropriateness.”

Economic Impact

The integration of cannabis into the California State Fair highlights not only changing societal attitudes but also the economic potential of the cannabis market. Reports indicate that some attendees are spending upwards of $300 on cannabis products, underscoring the growing consumer interest in cannabis-infused goods

As the fair progresses, it sets a precedent for future events, signaling a shift toward the normalization of cannabis consumption in public spaces. The California State Fair’s decision to embrace cannabis represents a significant milestone in the evolving landscape of cannabis culture in the United States.

Hemp-Derived THC Beverage Boom Ignited by Legal Clause in Minnesota

nacbcomdev on July 26, 2024

MINNEAPOLIS, MN — A minor legal clause has ignited a significant boom in Minnesota’s hemp derived THC beverage market, revolutionizing consumer engagement with cannabis products. Following the passage of legislation in May 2022 permitting the sale of hemp-derived THC edibles and beverages in mainstream retail outlets, the state has witnessed an explosion in the availability and popularity of these products.

The new law, effective July 1, 2022, allows beverages containing up to 5 milligrams of THC per serving and a maximum of 10 milligrams per package to be sold without the stringent regulations typically associated with cannabis products. This legislative change has enabled breweries, taprooms, and retailers to serve THC-infused drinks alongside traditional alcoholic beverages, significantly altering Minnesota’s cannabis landscape.

Market Growth and Consumer Demand

Local businesses have responded overwhelmingly positively. Taprooms like Headflyer Brewing in northeast Minneapolis have eagerly embraced the opportunity to offer THC beverages on tap, allowing consumers to sample products in a social setting. “This move allows consumers more flexibility to sample and savor the beverages on-site, making it a more accessible option compared to buying a whole can,” said Dan Schnabel, taproom manager at Headflyer Brewing.

According to the Minnesota Department of Revenue, the state generated over $11.5 million in revenue from hemp-derived THC product sales between July and May of this year. The relaxed regulations have led to nearly 3,900 businesses selling hemp-derived goods by mid-June, with projections indicating that Minnesota could achieve annual cannabis sales nearing $1.5 billion by the end of the decade.

A New Era for Cannabis Beverages

The burgeoning market has attracted not only seasoned cannabis consumers but also new demographics, including non-smokers and older adults. Industry insiders report that the availability of low-dose THC beverages has helped demystify cannabis for many consumers, making it as accessible as purchasing alcohol.

Leili Fatehi, a partner at Blunt Strategies, noted, “It has exposed an entire state of consumers to the fact that they can purchase these products the same way they can purchase alcohol. And the sky hasn’t fallen.”

Future of Cannabis in Minnesota

As Minnesota prepares for the upcoming legalization of recreational marijuana sales, the state is well-positioned to leverage its existing hemp-derived THC market. The establishment of the Office of Cannabis Management and the ongoing development of regulatory frameworks will further shape the landscape for cannabis products in the state.

With the groundwork laid for a thriving market, Minnesota’s experience serves as a model for other states considering similar legislative changes. As interest in hemp-derived THC beverages continues to grow, the state is poised to lead the way in creating a regulated and accessible cannabis marketplace.

Stakeholders are optimistic about the future of cannabis in Minnesota, anticipating that the momentum generated by this legal clause will pave the way for continued innovation and growth in the industry.

Cannabis and Pets: Investigating Cannabis-Derived Products for Our Pets

nacbcomdev on July 4, 2024

As our comprehension of the potential advantages of cannabis broadens, the curiosity surrounding its application for our four-legged friends also grows. Cannabis-derived products, notably CBD oil, are gaining momentum as solutions for various pet conditions, ranging from anxiety to pain relief. In this article, we’ll look into the realm of cannabis and pets, exploring how these products are making a significant impact on pet care.

Understanding CBD for Pets:

CBD, or cannabidiol, is one of the many compounds found in the cannabis plant. Unlike its counterpart THC (tetrahydrocannabinol), CBD is non-psychoactive, making it a safe option for pets. It interacts with the endocannabinoid system, which exists in humans and animals, influencing functions like pain, inflammation, and mood.

CBD for Anxiety:

Anxiety is not limited to humans; our pets can also suffer from this condition. Stressors like separation anxiety, thunderstorms, or visits to the vet can cause significant distress in animals. CBD has shown promise as an anxiety-reducing compound, offering a sense of calm to our furry friends. Pet owners have reported positive results in alleviating anxiety-related behaviors when incorporating CBD into their pet’s routine.

Pain Relief for Pets:

Whether due to old age, injury, or chronic conditions, pets can experience discomfort and pain. CBD’s potential for pain relief has piqued interest among pet owners and veterinarians. It may help reduce inflammation and relieve pain without the side effects associated with some traditional medications.

CBD Products for Pets:

CBD for pets is available in various forms, such as oils, tinctures, treats, and capsules designed with the particular requirements and preferences of animals in consideration. When contemplating CBD for your pet, it’s vital to select high-quality products formulated specifically for pets to guarantee safety and effectiveness.

Seeking Guidance from a Veterinarian:

While CBD displays potential in pet care, it’s vital to seek advice from a veterinarian before incorporating any new supplements or treatments into your pet’s regimen. A veterinarian can offer recommendations regarding the proper dosage and closely monitor your pet’s response to CBD. Additionally, they can assess any underlying health issues that may necessitate alternative treatments.

Prioritizing Safety

Ensuring your pet’s safety is of the utmost importance. Store CBD products out of your pet’s reach to prevent accidental ingestion and follow the recommended storage guidelines. Keep a close eye on your pet’s reaction to CBD and adjust as needed. It’s crucial to use CBD products explicitly designed for pets and avoid human CBD products, as they may contain substances that could be harmful to animals.

The use of cannabis-derived products, particularly CBD, in pet care is an evolving field with potential benefits for our animal companions. As we continue to explore the possibilities of these products, it’s important to approach their use with care under the guidance of a qualified veterinarian. CBD may offer a new dimension in pet wellness, relieve anxiety and pain, and improve the quality of life for our beloved pets.

We support industry stakeholders elevate the cannabis economy to its full socio-economic promise.

Contact Us

Quick Links

Copyright ©2024 NACB. All rights reserved.

Privacy Policy

|

Cookie Policy

|

Sitemap

We’d Love to Hear from You.

Please reach out to us with any questions, feedback, or inquiries. We’re here to help and eager to connect with you.